Vai al contenuto principale della pagina

Mucus hypersecretion in respiratory disease [[electronic resource]]



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Titolo: Mucus hypersecretion in respiratory disease [[electronic resource]] Visualizza cluster
Pubblicazione: Chichester, West Sussex, England ; ; Hoboken, NJ, USA, : Wiley, 2002
Descrizione fisica: 1 online resource (304 p.)
Disciplina: 616.2
Soggetto topico: Mucous membrane
Respiratory organs - Diseases
Altri autori: ChadwickDerek  
GoodeJamie  
Note generali: "Editors, Derek J. Chadwick and Jamie A. Goode"--P. [v].
"Symposium on Mucus Hypersecretion in Respiratory Disease, held at the Novartis Foundation, London, 26-28 February 2002"--P. [v].
Nota di bibliografia: Includes bibliographical references and indexes.
Nota di contenuto: MUCUS HYPERSECRETION IN RESPIRATORY DISEASE; Contents; Participants; Chair's introduction; Epidemiological studies in mucus hypersecretion; Discussion; Post-secretory fate of host defence components in mucus; Discussion; Mechanisms of submucosal gland morphogenesis in the airway; Discussion; Mucin-producing elements and inflammatory cells; Discussion; Respiratory tract mucins: structure and expression patterns; Discussion; Development and validation of a lectin-based assay for the quantitation of rat respiratory mucin; Discussion; Regulation of mucin secretion from in vitro cellular models
DiscussionOscillations of pH inside the secretory granule control the gain of Ca(2+) release for signal transduction in goblet cells exocytosis; Discussion; A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction; Discussion; Mechanisms by which Gram-positive bacteria and tobacco smoke stimulate mucin induction through the epidermal growth factor receptor (EGFR); Discussion; Non-allergic models of mucous cell metaplasia and mucus hypersecretion in rat nasal and pulmonary airways; Discussion
Cytokine regulation of mucus production in a model of allergic asthmaDiscussion; The role of apoptotic regulators in metaplastic mucous cells; Discussion; Current and future therapies for airway mucus hypersecretion; Discussion; Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases; Discussion; Final general discussion; Index of contributors; Subject index
Sommario/riassunto: A number of chronic respiratory diseases including chronic bronchitis, asthma, cystic fibrosis and bronchiectasis are characterized by mucus hypersecretion. Following damage to the airway epithelium, a repair process of dedifferentiation, regenerative proliferation and redifferentiation takes place that is invariably accompanied by mucus hypersecretion as a key element in the host defence mechanism. In chronic respiratory diseases, however, excessive mucus production leads to a pathological state with increased risk of infection, hospitalization and morbidity. An understanding of the mechanism
Titolo autorizzato: Mucus hypersecretion in respiratory disease  Visualizza cluster
ISBN: 1-280-27111-6
9786610271115
0-470-66827-X
0-470-85929-6
0-470-86079-0
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910841344003321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Serie: Novartis Foundation symposium ; ; 248.